This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
Lucy Chard
16 Jul 2024

CPHI Podcast Series: analysing supplier audits with the PSCI

This episode of the CPHI Podcast Series, hosted by Digital Editor Lucy Chard, goes through the results from the recent audits from the PSCI conducted on suppliers across the pharmaceutical industry, looking into ESG outcomes. 

In this episode we’re focusing on some of the work from one of our valued partners at CPHI, the PSCI. 

The PSCI have recently published the results from their supplier audits and to talk us through these Digital Editor Lucy Chard is joined by Birgit Skuballa. Skuballa represents Bayer in the PSCI as Chair of the PSCI Audit Committee, and gives us a information on how these audits work, the different pillars across the pharmaceutical industry that the audits address, how this changes regionally, and importantly, how the PSCI work with their members and the participating suppliers afterwards to improve their practices.

Skuballa works with the German Company Bayer AG. She leads the global HSE Audits & Supplier Management team. She holds a PhD in Organic Chemistry and has been around 30 years within the Pharma/Chemical Industry, assuming different roles in the areas of active ingredient and pharmaceutical production, GMP/Quality Management & Audits, HSE Management & internal Audits, Supplier Audit Management (PSCI, HSE, Social). She represents Bayer in the PSCI as Chair of the PSCI Audit Committee. 

The PSCI audits examine suppliers and those suggested by member companies based on the PSCI Principles of Ethics, Labor & Human Rights, Health & Safety, Environment, and Management Systems. The audits include examination of facilities according to a careful laid out process, as well as interviews with relevent stakeholders. After the audit is completed, the PSCI produce a Corrective Action Plan, showing exactly how companies can improve upon their weaker points. 

Skuballa impresses how the audits are not about policing companies, but more about working together and supporting them in their journeys to improve. 

To listen to the full episode now, see here

Mentioned Companies
BAYER AG
View company profile
PSCI
View company profile
Lucy Chard
Digital Editor - Pharma

Related News

  • News A Day in the Life of Oncology Start-Up Co-Founder & CEO

    This Women's month we are highlighting stories of women in the pharma industry (building on what we do every month to support women), so for the Day in the Life of we are speaking to Sharon Cunningham who is the Co-founder and CEO of Shorla On...
  • News Women in Pharma: Manufacturing personal and team success

    Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive...
  • News Women in Pharma: Connecting accessible pharma packaging to patients – a Pharmapack Special

    Throughout our Women in Pharma series, we aim to highlight how CPHI events encourage discussions around diversity, equity, and inclusion initiatives in the pharmaceutical industry. 
  • News Women in Pharma: Delivering on global access to medicines

    Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive...
  • News Women in Pharma: Our hopes for 2025 and beyond

    Our last instalment for 2024 of the Women in Pharma series brings you messages direct from the Informa Markets CPHI team as they discuss the advice and insights they have carried throughout their roles working at CPHI, and what they hope to see for the...
  • News Closing 2024 with Editors' picks of top articles from the past year

    Coming to the end of 2024 and it’s certainly been a busy year, for CPHI and for the rest of the pharmaceutical and healthcare industry. Topics of conversation throughout the last 12 months have been varied, touching on the technical, to the polit...
  • News Day in the Life of a Green Chief Financial Officer

    Our latest look into the daily lives of the people behind the pharma community brings us to meet Juan Jose Piedra Galan, Global Financial Planning & Analysis Manager for Galderma, otherwise known as 'The Green CFO'.  
  • News Women in Pharma: Reflections from Behind the Scenes

    In this instalment of our monthly series, the team that brings you the Women in Pharma series each month sits down for a heart-to-heart on what the series means to them, and how they hope to continue their work in the future.